54
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Proliferation of latently infected CD4 + T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The latent reservoir for HIV-1 in resting CD4 + T cells prevents cure with antiretroviral therapy. Hosmane et al. provide evidence supporting the hypothesis that a larger fraction of cells in the reservoir is generated by cell proliferation than by direct infection.

          Abstract

          A latent reservoir for HIV-1 in resting CD4 + T lymphocytes precludes cure. Mechanisms underlying reservoir stability are unclear. Recent studies suggest an unexpected degree of infected cell proliferation in vivo. T cell activation drives proliferation but also reverses latency, resulting in productive infection that generally leads to cell death. In this study, we show that latently infected cells can proliferate in response to mitogens without producing virus, generating progeny cells that can release infectious virus. Thus, assays relying on one round of activation underestimate reservoir size. Sequencing of independent clonal isolates of replication-competent virus revealed that 57% had env sequences identical to other isolates from the same patient. Identity was confirmed by full-genome sequencing and was not attributable to limited viral diversity. Phylogenetic and statistical analysis suggested that identical sequences arose from in vivo proliferation of infected cells, rather than infection of multiple cells by a dominant viral species. The possibility that much of the reservoir arises by cell proliferation presents challenges to cure.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

          The hypothesis that quiescent CD4+ T lymphocytes carrying proviral DNA provide a reservoir for human immunodeficiency virus-type 1 (HIV-1) in patients on highly active antiretroviral therapy (HAART) was examined. In a study of 22 patients successfully treated with HAART for up to 30 months, replication-competent virus was routinely recovered from resting CD4+ T lymphocytes. The frequency of resting CD4+ T cells harboring latent HIV-1 was low, 0.2 to 16.4 per 10(6) cells, and, in cross-sectional analysis, did not decrease with increasing time on therapy. The recovered viruses generally did not show mutations associated with resistance to the relevant antiretroviral drugs. This reservoir of nonevolving latent virus in resting CD4+ T cells should be considered in deciding whether to terminate treatment in patients who respond to HAART.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.

            Treatment of infected patients with ABT-538, an inhibitor of the protease of human immunodeficiency virus type 1 (HIV-1), causes plasma HIV-1 levels to decrease exponentially (mean half-life, 2.1 +/- 0.4 days) and CD4 lymphocyte counts to rise substantially. Minimum estimates of HIV-1 production and clearance and of CD4 lymphocyte turnover indicate that replication of HIV-1 in vivo is continuous and highly productive, driving the rapid turnover of CD4 lymphocytes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

              The capacity of HIV-1 to establish latent infection of CD4+ T cells may allow viral persistence despite immune responses and antiretroviral therapy. Measurements of infectious virus and viral RNA in plasma and of infectious virus, viral DNA and viral messenger RNA species in infected cells all suggest that HIV-1 replication continues throughout the course of infection. Uncertainty remains over what fraction of CD4+ T cells are infected and whether there are latent reservoirs for the virus. We show here that during the asymptomatic phase of infection there is an extremely low total body load of latently infected resting CD4+ T cells with replication-competent integrated provirus (<10(7) cells). The most prevalent form of HIV-1 DNA in resting and activated CD4+ T cells is a full-length, linear, unintegrated form that is not replication competent. The infection progresses even though at any given time in the lymphoid tissues integrated HIV-1 DNA is present in only a minute fraction of the susceptible populations, including resting and activated CD4+ T cells and macrophages.
                Bookmark

                Author and article information

                Journal
                J Exp Med
                J. Exp. Med
                jem
                jem
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                3 April 2017
                3 April 2017
                : 214
                : 4
                : 959-972
                Affiliations
                [1 ]Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205
                [2 ]Department of Biomedical Informatics, Columbia University Medical Center, New York, NY 10032
                [3 ]AIDS and Cancer Virus Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702
                [4 ]Howard Hughes Medical Institute, Baltimore, MD 21205
                Author notes
                Correspondence to Robert F. Siliciano: rsiliciano@ 123456jhmi.edu
                Author information
                http://orcid.org/0000-0003-1862-6012
                http://orcid.org/0000-0001-6712-3775
                http://orcid.org/0000-0002-1764-1993
                Article
                20170193
                10.1084/jem.20170193
                5379987
                28341641
                35c6c8af-365f-4e3e-b437-c1b3f9a54e45
                © 2017 Hosmane et al.

                This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

                History
                : 29 January 2017
                : 14 February 2017
                : 15 February 2017
                Funding
                Funded by: National Institutes of Health, DOI https://doi.org/10.13039/100000002;
                Award ID: UM1AI126611
                Award ID: UM1AI126603
                Award ID: UM1AI126620
                Funded by: American Foundation for Aids Research, DOI https://doi.org/10.13039/100001117;
                Award ID: 108165-50-RGRL
                Funded by: National Institutes of Health, DOI https://doi.org/10.13039/100000002;
                Award ID: 43222
                Funded by: Howard Hughes Medical Institute, DOI https://doi.org/10.13039/100000011;
                Funded by: Bill and Melinda Gates Foundation, DOI https://doi.org/10.13039/100000865;
                Award ID: OPP1115715
                Funded by: National Cancer Institute, DOI https://doi.org/10.13039/100000054;
                Funded by: National Institutes of Health, DOI https://doi.org/10.13039/100000002;
                Award ID: HHSN261200800001E
                Funded by: amfAR, DOI https://doi.org/10.13039/100001117;
                Award ID: 109511-61-RKRL
                Categories
                Research Articles
                Article
                312

                Medicine
                Medicine

                Comments

                Comment on this article